stock delisting Interpace Biosciences Receives Nasdaq Delisting Notice, Initiates Restructuring The notice was issued due to the company's extended period of non-compliance with the minimum $2.5 million stockholder's equity requirement for continued listing. T2 Biosystems Regains Compliance With Nasdaq Listing Requirements In April the firm received notice that it wasn't in compliance because its common stock didn't maintain a minimum bid price of $1.00 for 30 consecutive business days. T2 Biosystems Receives Nasdaq Warning Letter The Lexington, Massachusetts-based company also terminated a purchase agreement and raised the amount in it may raise in a public offering of its common stock to $95. Genetic Technologies Receives Nasdaq Delisting Notification The company will not be allowed to submit another plan for meeting the Nasdaq's listing requirements. Nasdaq Warns Biocept Over Listing Requirement The firm has a 180-day grace period in which to regain compliance, by maintaining a $1.00 minimum closing bid price for at least 10 consecutive business days. Aug 23, 2019 OpGen Stock Non-Compliant With Nasdaq Listing Requirement Jul 8, 2019 Nasdaq Warns Co-Diagnostics Over Listing Requirement Apr 26, 2019 Precipio to Effect 1-for-15 Reverse Stock Split Jan 18, 2019 NantHealth Receives Nasdaq Delisting Notice Sep 28, 2018 Precipio Gets Extension to Meet Nasdaq Listing Requirement Apr 2, 2018 Precipio Out of Compliance With Nasdaq Listing Requirement Jan 17, 2018 OpGen to Execute 1-for-25 Reverse Stock Split Dec 27, 2017 OpGen to Meet With Nasdaq Panel to Stave Off Delisting Aug 4, 2017 HTG Molecular Out of Compliance with Nasdaq Listing Requirement Jul 24, 2017 Genetic Technologies Facing Nasdaq Delisting Jun 22, 2017 OpGen Warned by Nasdaq of Non-Compliance May 15, 2017 OpGen Falls Short on Nasdaq Listing Requirement Apr 13, 2017 Interpace Diagnostics Regains Nasdaq Compliance Feb 21, 2017 HTG Molecular Appeals Delisting Determination by Nasdaq Dec 28, 2016 Interpace Effecting a 1-for-10 Reverse Stock Split Nov 30, 2016 Interpace Diagnostics Faces Nasdaq Delisting Nov 28, 2016 Signal Genetics Regains Compliance With Nasdaq Listing Requirement Oct 10, 2016 Great Basin Shares to Be Delisted From Nasdaq Sep 7, 2016 Great Basin Scientific Receives Nasdaq Delisting Warning Jun 24, 2016 Great Basin to Stay Listed on Nasdaq Load More Breaking News Variant Identified in Amish Population Appears to Protect From Cardiovascular Disease Danaher Prices $1B Offering of Senior Notes Discovery Life Sciences Acquires Contract Research Firm In Vitro ADMET Laboratories Audere Gets FDA Emergency Use Authorization for SARS-CoV-2 At-Home Sample Collection Kit GenomeWeb Index Falls 6 Percent in November as Emergence of Omicron Spooks Markets Sequencing-Based MRD Detection in Bone Marrow May Predict ALL Relapse After CAR T-Cell Therapy The Scan Science Confidence Boost The New York Times reports that a new poll finds trust in science and scientists has increased with the COVID-19 pandemic. Appeal and Funds Some grant applications denied funding due to an Australian Research Council rule change have now been funded following an appeal, the Guardian reports. Surveillance for Variants Vox writes that the detection of the Omicron SARS-CoV-2 variant highlights the need for improved viral genomic surveillance. Nature Papers Examine Taxonomic Gaps in Plant Sequencing, SARS-CoV-2-Human Interactome In Nature this week: plant genome sequencing dominated by affluent countries, and more.